Skip navigation
Watchlist Sponsored By :


Current DateTime: 05:12:16 25 Nov 2009
LinksList Documentid: 24355697
  • Runway Angels

      The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.

  • Smartphone Guide

      Here's a need-to-know guide to nine devices, based on features, price, network and platform.

  • Wines for the Holidays

      Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES


Current DateTime: 05:12:16 25 Nov 2009
LinksList Documentid: 33793611
  • How Well Do You Know Your Bird?

      Let's talk turkey. Test your turkey knowledge and perhaps pick up a bit of trivia to trot out at your holiday meal.

  • A Healthier & Wealthier You

      Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.

  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?


Current DateTime: 05:12:16 25 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
Merck Ends Lobby for Mandatory Cervical Cancer Vaccinations
By: Reuters | 21 Feb 2007 | 09:50 AM ET
Text Size

Drugmaker Merck & Co. said it would stop lobbying state legislatures to make it mandatory for schoolgirls to be inoculated with its new cervical cancer vaccine.

The company said it made the decision after re-evaluating its lobbying program, which has generated fierce debate with some religious organizations saying it could encourage promiscuity and parents groups questioning the need for such a widespread vaccination program.

Merck's [MRK  Loading...      ()   ] Gardasil is the first and only vaccine against cervical cancer.
Approved in 2006 for females aged 9 to 26, it works against strains of the human papillomavirus (HPV), a sexually transmitted disease responsible for about 70% of cervical cancer cases.

Earlier this month, Texas became the first U.S. state to require that all 11- and 12-year-old girls be vaccinated against HPV. Republican Gov. Rick Perry said parents could opt out of mandatory vaccinations for their children if they objected for reasons including religious beliefs.

About 20 U.S. states had been considering mandating the vaccine, many for girls before they entered the sixth grade. The vaccine, given in a series of three injections at a price of $360, has been endorsed by medical organizations such as the American Academy of Pediatrics.

In December, Merck said it was looking into providing Gardasil at much lower prices in developing countries and to  make it available within months.

Richard Haupt, executive director of medical affairs for vaccines at Merck, said the media publicity had become a "potential distraction" that was interfering with the company's objective of promoting widespread use of the product.

"We've reevaluated our position, but certainly plan to continue education efforts in different venues, such as with legislators, health departments and coalition groups in various states," Haupt said.

The company reaffirmed it continues to expect combined revenue this year of $2.8 billion to $3.2 billion from its array of vaccines, including ones to prevent shingles and infections with rotavirus.

GlaxoSmithKline [GSK  Loading...      ()   ] is expected to file in April for U.S. regulatory approval for its cervical cancer vaccine Cervarix. Cervical cancer kills some 300,000 women worldwide each year.

Copyright 2009 Reuters. Click for restrictions.
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.
  • Eric Schmidt pledges to create a virtual copy of the Iraq National Museum at Google’s expense.
  • Bill Griffeth is taking a leave of absence from CNBC and Power Lunch for a year. Here's a message from Bill.
  • More shoppers than ever plan to comparison-shop this season. Who will benefit?
  • It may be the most unusual guide to business you'll read.
  • Cut Credit cards
  • How can you get out of debt and back on the road to recovery? Follow these ten steps.
ADD COMMENTS
Remaining characters


Current DateTime: 12:56:54 25 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 10:38:04 25 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:32:23 25 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 10:38:05 25 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters